Sysmex (OTCMKTS:SSMXY) Sets New 52-Week Low at $15.68

Sysmex Co. (OTCMKTS:SSMXY) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as $15.68 and last traded at $15.70, with a volume of 96602 shares traded. The stock had previously closed at $16.01.

Sysmex Stock Performance

The company has a market capitalization of $9.87 billion, a P/E ratio of 31.32 and a beta of 0.66. The business has a 50-day moving average of $17.63 and a 200-day moving average of $17.52. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.10 and a quick ratio of 2.27.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Friday, February 9th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.03). Sysmex had a return on equity of 11.15% and a net margin of 10.25%. The business had revenue of $770.84 million for the quarter. On average, sell-side analysts anticipate that Sysmex Co. will post 0.53 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.